110 related articles for article (PubMed ID: 15471670)
1. Computed tomography in TN stage evaluation of oral cavity and oropharyngeal cancers.
Malard O; Toquet C; Jegoux F; Bordure P; Beauvillain de Montreuil C; Gayet-Delacroix M
Clin Imaging; 2004; 28(5):360-7. PubMed ID: 15471670
[TBL] [Abstract][Full Text] [Related]
2. Comparison between computed tomography and clinical evaluation in tumour/node stage and follow-up of oral cavity and oropharyngeal cancer.
Figueiredo PT; Leite AF; Freitas AC; Nascimento LA; Cavalcanti MG; Melo NS; Guerra EN
Dentomaxillofac Radiol; 2010 Mar; 39(3):140-8. PubMed ID: 20203275
[TBL] [Abstract][Full Text] [Related]
3. [Computed tomography for the preoperative classification of oral cavity and oropharyngeal carcinomas].
Wolfensberger M; Jecklin A; Franze I; Kikinis R
Laryngol Rhinol Otol (Stuttg); 1987 Jun; 66(6):324-8. PubMed ID: 3626715
[TBL] [Abstract][Full Text] [Related]
4. Computed tomography and lymphoscintigraphy to identify lymph node metastases and lymphatic drainage pathways in oral and oropharyngeal squamous cell carcinomas.
Freire AR; Lima EN; Almeida OP; Kowalski LP
Eur Arch Otorhinolaryngol; 2003 Mar; 260(3):148-52. PubMed ID: 12687387
[TBL] [Abstract][Full Text] [Related]
5. [Computed tomographic appearance of the recurrent patterns of oropharyngeal and oral cavity squamous cell carcinomas].
Sasaki F; Kido C
Rinsho Hoshasen; 1988 Oct; 33(10):1071-7. PubMed ID: 3210328
[No Abstract] [Full Text] [Related]
6. Do PET and SNB reduce the rate of elective neck dissection? A hypothesis still in need of validation.
Smith BD; Lally BE; Haffty BG; Wilson LD
J Clin Oncol; 2005 Apr; 23(12):2874-5; author reply 2875-6. PubMed ID: 15838015
[No Abstract] [Full Text] [Related]
7. Utility of FDG PET in patients with squamous cell carcinomas of the oral cavity.
Kim SY; Roh JL; Kim JS; Ryu CH; Lee JH; Cho KJ; Choi SH; Nam SY
Eur J Surg Oncol; 2008 Feb; 34(2):208-15. PubMed ID: 17482789
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors influencing contralateral neck lymph node metastases in oral and oropharyngeal carcinoma.
Capote-Moreno A; Naval L; Muñoz-Guerra MF; Sastre J; Rodríguez-Campo FJ
J Oral Maxillofac Surg; 2010 Feb; 68(2):268-75. PubMed ID: 20116694
[TBL] [Abstract][Full Text] [Related]
9. NBI utility in the pre-operative and intra-operative assessment of oral cavity and oropharyngeal carcinoma.
Tirelli G; Piovesana M; Gatto A; Torelli L; Di Lenarda R; Boscolo Nata F
Am J Otolaryngol; 2017; 38(1):65-71. PubMed ID: 27773561
[TBL] [Abstract][Full Text] [Related]
10. [Computerized tomography of malignancies of the oral cavity, the oropharynx and hypopharynx and invasiveness].
Helmberger R; Jäger L; Grevers G; Reiser M
Radiologe; 1996 Mar; 36(3):193-8. PubMed ID: 8693081
[TBL] [Abstract][Full Text] [Related]
11. Positron emission tomography in combination with sentinel node biopsy reduces the rate of elective neck dissections in the treatment of oral and oropharyngeal cancer.
Kovács AF; Döbert N; Gaa J; Menzel C; Bitter K
J Clin Oncol; 2004 Oct; 22(19):3973-80. PubMed ID: 15459220
[TBL] [Abstract][Full Text] [Related]
12. Weight loss predicts mortality after recurrent oral cavity and oropharyngeal carcinomas.
Nguyen TV; Yueh B
Cancer; 2002 Aug; 95(3):553-62. PubMed ID: 12209747
[TBL] [Abstract][Full Text] [Related]
13. Computed tomographic evaluation of regional lymph node involvement in cancer of the oral cavity and oropharynx.
Close LG; Merkel M; Vuitch MF; Reisch J; Schaefer SD
Head Neck; 1989; 11(4):309-17. PubMed ID: 2753699
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant radiochemotherapy of oral cavity and oropharyngeal cancer: evaluation of tumor response by CT differs from histopathologic response assessment in a significant fraction of patients.
Klug C; Keszthelyi D; Ploder O; Sulzbacher I; Voracek M; Wagner A; Millesi W; Kornek G; Kainberger F; Kermer C; Selzer E
Head Neck; 2004 Mar; 26(3):224-31. PubMed ID: 14999797
[TBL] [Abstract][Full Text] [Related]
15. [The clinical value of computed tomography in the pretherapeutic T-staging of orofacial tumors].
Lenz M; Bongers H; Ozdoba C; Skalej M
Rofo; 1989 Aug; 151(2):138-44. PubMed ID: 2548237
[TBL] [Abstract][Full Text] [Related]
16. Oral cavity and oropharyngeal squamous cell cancer: key imaging findings for staging and treatment planning.
Trotta BM; Pease CS; Rasamny JJ; Raghavan P; Mukherjee S
Radiographics; 2011; 31(2):339-54. PubMed ID: 21415183
[TBL] [Abstract][Full Text] [Related]
17. Sentinel node biopsy as staging tool in a multimodality treatment approach to cancer of the oral cavity and the oropharynx.
Kovács AF; Landes CA; Hamscho N; Risse JH; Berner U; Menzel C
Otolaryngol Head Neck Surg; 2005 Apr; 132(4):570-6. PubMed ID: 15806047
[TBL] [Abstract][Full Text] [Related]
18. Development of a new staging system for recurrent oral cavity and oropharyngeal squamous cell carcinoma.
Lacy PD; Spitznagel EL; Piccirillo JF
Cancer; 1999 Oct; 86(8):1387-95. PubMed ID: 10526264
[TBL] [Abstract][Full Text] [Related]
19. A new CT dynamic maneuver "Mouth Opened with Tongue Extended" can improve the clinical TNM staging of oral cavity and oropharynx squamous cell carcinomas.
Bron G; Scemama U; Villes V; Fakhry N; Salas S; Chagnaud C; Bendahan D; Varoquaux A
Oral Oncol; 2019 Jul; 94():41-46. PubMed ID: 31178211
[TBL] [Abstract][Full Text] [Related]
20. Is the new TNM (1997) the best system for predicting prognosis?
Carinci F; Farina A; Longhini L; Urso RG; Pelucchi S; Calearo C
Int J Oral Maxillofac Surg; 1999 Jun; 28(3):203-5. PubMed ID: 10355943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
